Clinical Trial Update: Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

This document notes the completion of a Phase 3 trial assessing preoperative twice-daily chemoradiation in addition to chemotherapy before surgery for Stage III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Heidelberg University | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED